{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:40:54Z","timestamp":1790851254454,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["IWT 150178"],"award-info":[{"award-number":["IWT 150178"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00520-019-05101-8","type":"journal-article","created":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T23:04:21Z","timestamp":1572217461000},"page":"439-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-6169","authenticated-orcid":false,"given":"Tessa","family":"De Vrieze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Nevelsteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8491-6264","authenticated-orcid":false,"given":"Sarah","family":"Thomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-2836","authenticated-orcid":false,"given":"An","family":"De Groef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-045X","authenticated-orcid":false,"given":"Wiebren A. A.","family":"Tjalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4927-0434","authenticated-orcid":false,"given":"Nick","family":"Gebruers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-7080","authenticated-orcid":false,"given":"Nele","family":"Devoogdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"issue":"5","key":"5101_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386","journal-title":"Int J Cancer"},{"issue":"1","key":"5101_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2354.2009.01141.x","volume":"20","author":"N Devoogdt","year":"2011","unstructured":"Devoogdt N, Van Kampen M, Christiaens MR et al (2011) Short- and long-term recovery of upper limb function after axillary lymph node dissection. Eur J Cancer Care 20(1):77\u201386","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"5101_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00404-017-4421-x","volume":"296","author":"K Kast","year":"2017","unstructured":"Kast K, Schoffer O, Link T, Forberger A, Petzold A, Niedostatek A, Werner C, Klug SJ, Werner A, Gatzweiler A, Richter B, Baretton G, Wimberger P (2017) Trastuzumab and survival of patients with metastatic breast cancer. Arch Gynecol Obstet 296(2):303\u2013312","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"5101_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00432-017-2539-7","volume":"144","author":"H Eggemann","year":"2018","unstructured":"Eggemann H, Altmann U, Costa SD, Ignatov A (2018) Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer. J Cancer Res Clin Oncol 144(2):337\u2013341","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5101_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/0284186X.2017.1403042","volume":"57","author":"P Christiansen","year":"2018","unstructured":"Christiansen P, Carstensen SL, Ejlertsen B et al (2018) Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol 57(1):19\u201325","journal-title":"Acta Oncol"},{"issue":"2","key":"5101_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-017-4331-4","volume":"165","author":"TI Yoon","year":"2017","unstructured":"Yoon TI, Hwang UK, Kim ET, Lee S, Sohn G, Ko BS, Lee JW, Son BH, Kim S, Ahn SH, Kim HJ (2017) Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy. Breast Cancer Res Treat 165(2):311\u2013320","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5101_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/07347332.2013.874004","volume":"32","author":"EB Beckjord","year":"2014","unstructured":"Beckjord EB, Reynolds KA, van Londen GJ, Burns R, Singh R, Arvey SR, Nutt SA, Rechis R (2014) Population-level trends in posttreatment cancer survivors\u2019 concerns and associated receipt of care: results from the 2006 and 2010 LIVESTRONG surveys. J Psychosoc Oncol 32(2):125\u2013151","journal-title":"J Psychosoc Oncol"},{"issue":"8","key":"5101_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.pmrj.2012.05.003","volume":"4","author":"BB Lasinski","year":"2012","unstructured":"Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, Green JM, Stewart BR, Cormier JN, Armer JM (2012) A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R 4(8):580\u2013601","journal-title":"PM R"},{"issue":"6","key":"5101_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B et al (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500\u2013515","journal-title":"Lancet Oncol"},{"issue":"7","key":"5101_CR10","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/pon.3201","volume":"22","author":"MR Fu","year":"2013","unstructured":"Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM (2013) Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psycho-oncology 22(7):1466\u20131484","journal-title":"Psycho-oncology"},{"key":"5101_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-84628-793-0_3","volume-title":"Lymphedema","author":"Cheryl L. Morgan","year":"2008","unstructured":"Morgan CL, Lee BB (2008) Classification and staging of lymphedema. In Lymphedema. Springer, USA, pp 21\u201330"},{"issue":"6","key":"5101_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/pon.4239","volume":"26","author":"J Boyages","year":"2017","unstructured":"Boyages J, Xu Y, Kalfa S, Koelmeyer L, Parkinson B, Mackie H, Viveros H, Gollan P, Taksa L (2017) Financial cost of lymphedema borne by women with breast cancer. Psycho-oncology. 26(6):849\u2013855","journal-title":"Psycho-oncology."},{"issue":"6","key":"5101_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00006199-200311000-00004","volume":"52","author":"JM Armer","year":"2003","unstructured":"Armer JM, Radina ME, Porock D, Culbertson SD (2003) Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52(6):370\u2013379","journal-title":"Nurs Res"},{"issue":"12","key":"5101_CR14","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12):2007\u20132014","journal-title":"J Clin Oncol"},{"key":"5101_CR15","unstructured":"(2013) The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 46(1):1\u201311"},{"key":"5101_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejogrb.2017.07.035","volume":"216","author":"N Gebruers","year":"2017","unstructured":"Gebruers N, Verbelen H, De Vrieze T et al (2017) Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: a best practice guideline. Eur J Obstet Gynecol Reprod Biol 216:245\u2013253","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5101_CR17","unstructured":"(2006) International Lymphoedema Framework I. Best Practice for the Management of Lymphoedema: International Consensus"},{"issue":"10","key":"5101_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1\u2013e34","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"5101_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/14737167.2016.1246961","volume":"16","author":"B Wijnen","year":"2016","unstructured":"Wijnen B, Van Mastrigt G, Redekop WK et al (2016) How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3\/3). Expert Rev Pharmacoecon Outcomes Res 16(6):723\u2013732","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"5101_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/02841860902755251","volume":"48","author":"A Karki","year":"2009","unstructured":"Karki A, Anttila H, Tasmuth T et al (2009) Lymphoedema therapy in breast cancer patients: a systematic review on effectiveness and a survey of current practices and costs in Finland. Acta Oncol 48(6):850\u2013859","journal-title":"Acta Oncol"},{"issue":"11","key":"5101_CR21","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/jdv.14442","volume":"31","author":"M Gutknecht","year":"2017","unstructured":"Gutknecht M, Herberger K, Klose K et al (2017) Cost-of-illness of patients with lymphoedema. J Eur Acad Dermatol Venereol 31(11):1930\u20131935","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"5101_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00520-014-2539-y","volume":"23","author":"KH Schmitz","year":"2015","unstructured":"Schmitz KH, DiSipio T, Gordon LG et al (2015) Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care. Support Care Cancer 23(6):1807\u20131817","journal-title":"Support Care Cancer"},{"issue":"1","key":"5101_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/lrb.2017.0021","volume":"16","author":"CJ Moffatt","year":"2018","unstructured":"Moffatt CJ, Doherty DC, Franks PJ, Mortimer PS (2018) Community-based treatment for chronic edema: an effective service model. Lymphat Res Biol 16(1):92\u201399","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"5101_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.amjsurg.2015.06.015","volume":"211","author":"MN Basta","year":"2016","unstructured":"Basta MN, Fox JP, Kanchwala SK, Wu LC, Serletti JM, Kovach SJ, Fosnot J, Fischer JP (2016) Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg 211(1):133\u2013141","journal-title":"Am J Surg"},{"key":"5101_CR25","doi-asserted-by":"crossref","unstructured":"Dean LT, Moss SL, Ransome Y et al (2018) \u201cIt still affects our economic situation\u201d: long-term economic burden of breast cancer and lymphedema. Support Care Cancer","DOI":"10.1007\/s00520-018-4418-4"},{"issue":"1","key":"5101_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2522\/ptj.20100167","volume":"92","author":"NL Stout","year":"2012","unstructured":"Stout NL, Pfalzer LA, Springer B, Levy E, McGarvey C, Danoff JV, Gerber LH, Soballe PW (2012) Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther 92(1):152\u2013163","journal-title":"Phys Ther"},{"issue":"5","key":"5101_CR27","first-page":"234","volume":"18","author":"SP Bilir","year":"2012","unstructured":"Bilir SP, DeKoven MP, Munakata J (2012) Economic benefits of BIS-aided assessment of post-BC lymphedema in the United States. Am J Manag Care 18(5):234\u2013241","journal-title":"Am J Manag Care"},{"issue":"1","key":"5101_CR28","first-page":"27","volume":"46","author":"NL Stout","year":"2013","unstructured":"Stout NL, Weiss R, Feldman JL, Stewart BR, Armer JM, Cormier JN, Shih YC (2013) A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004-2011). Lymphology 46(1):27\u201341","journal-title":"Lymphology"},{"issue":"12","key":"5101_CR29","doi-asserted-by":"publisher","first-page":"e114597","DOI":"10.1371\/journal.pone.0114597","volume":"9","author":"KM Brayton","year":"2014","unstructured":"Brayton KM, Hirsch AT, Brien OPJ et al (2014) Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS One 9(12):e114597","journal-title":"PLoS One"},{"issue":"5","key":"5101_CR30","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1524-4733.2009.00525.x","volume":"12","author":"S Knies","year":"2009","unstructured":"Knies S, Ament AJ, Evers SM, Severens JL (2009) The transferability of economic evaluations:testing the model of Welte. Value Health 12(5):730\u2013738","journal-title":"Value Health"},{"issue":"1","key":"5101_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/08870446.2014.953532","volume":"30","author":"SM Evers","year":"2015","unstructured":"Evers SM, Hiligsmann M, Adarkwah CC (2015) Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies. Psychol Health 30(1):52\u201371","journal-title":"Psychol Health"},{"issue":"4","key":"5101_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1017\/S0266462306051452","volume":"22","author":"V Alton","year":"2006","unstructured":"Alton V, Eckerlund I, Norlund A (2006) Health economic evaluations: how to find them. Int J Technol Assess Health Care 22(4):512\u2013517","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-05101-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-05101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T20:22:07Z","timestamp":1603743727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-05101-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5101"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-05101-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"8 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}